Respiree 1Bio
Decentralized clinical trials platform with digital biomarker development
Platform · Cloud SaaSCompany source
Company profile
About Respiree
Respiree is a medical technology company that has developed a comprehensive cardio-pulmonary remote patient monitoring platform designed to transform healthcare delivery across the care continuum. The company's flagship solutions include Respiree Care, an end-to-end enterprise-connected remote care platform, and Respiree 1Bio, a decentralized clinical trials platform integrating over 1000 pulmonary-cardio multi-modal biomarkers. Respiree's technology enables early deterioration detection with greater than 90% accuracy, providing healthcare systems with days of advance warning. The platform features cellular hubs for ease in remote data acquisition, comprehensive lung-cardio biomarker insights, and seamless software integration with enterprise and EHR systems. The solution includes customizable feedback and alert systems designed to reduce hospital readmissions and healthcare costs. The company serves multiple healthcare segments including hospital-at-home programs, chronic disease management, rehabilitation services, and pharmaceutical companies conducting decentralized clinical trials. Respiree's platform is US FDA 510(k) cleared, CE approved, and holds approvals from Australia's Therapeutic Goods Administration (TGA). The company maintains rigorous compliance standards including HIPAA certification, FDA cybersecurity certification, ISO 13485 QMS certification, and ISO 27001:2022 certification. Respiree is trusted by leading healthcare systems, medical technology companies, biopharma organizations, and patients globally.
Company description Respiree official website
Primary marketRemote Patient Monitoring & Wearables
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Respiree?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- cardio-pulmonary conditions
- chronic diseases requiring remote monitoring
- post-acute care and rehabilitation
Who it serves
- Biopharma
- Clinical Trial Sponsors
- Health Systems
- Medical Technology Companies
Deployment & integration
Cloud Saas · Hybrid deployment with recorded integration context.
Geographic context
MarketsAustralia · European Union · Southeast Asia · United States
Company sourceOfficial website
Company milestones
Platform expansion
President's Technology Award 2024, Featured at ATS 2022 RIS, Falling Walls Finalist 2022, Top 50 Southeast Asia Health Tech Startup 2022, HealthTech 250 Most Promising Early-stage Ventures 2022
Partnerships
Recorded partners
No partners are currently listed.
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Respiree Care
End-to-end enterprise-connected remote-care solution across healthcare's care continuum
Platform · HybridCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Vital Signs-Only Machine Learning Model for Acute Inpatient Deterioration: A Retrospective Multicenter Study.Mayo Clinic proceedings. Innovations, quality & outcomes · Oct 1, 2025
Clinical validation
Clinical-trial records
Accuracy of Respiree Pulse Oximeters With Profound HypoxiaNCT07785050 · Sponsor · COMPLETED
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Deterioration detection accuracy >90%
Days in advance warning for patient deterioration
Reduced readmissions and costs
Through customizable feedback and alert systems
Cost-effective drug trials
Via decentralized clinical trials platform
Accelerated patient outcomes
Through improved drug therapeutics development
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Respiree
Recent articles published on Respiree's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Remote Patient Monitoring & Wearables
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.